Parkinson's Disease Trial, Not Yet Recruiting NCT07356414 Sponsor: The University of Texas Health Science Center at San Antonio Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07356414
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 35 and 90 years of age who have swallowing difficulties
  • People who have been diagnosed with, or are suspected of having, Idiopathic Parkinson's Disease (either the tremor-dominant or rigidity-dominant type)
  • People whose Parkinson's disease disability level has been rated as Stage II or III on the Hoehn & Yahr scale in their most recent neurology assessment
  • People who have a swallowing concern confirmed by a recognised swallowing assessment tool (confirm with trial site)
  • People who are still able to eat and drink by mouth (confirmed by a standard food intake assessment score)
  • People who are able to walk independently
  • People whose Parkinson's medications have not changed in the four weeks before joining the study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose Parkinson's disease disability has been rated as Stage IV on the Hoehn & Yahr scale
  • People who are unable to follow a two-step instruction
  • People who have another neurological condition that may also cause swallowing difficulties
  • People who have been diagnosed with dementia, as determined by standard cognitive assessment scores
  • People experiencing severe depression, as measured by a standard depression assessment tool
  • People with severe uncontrolled movement of the head and neck that would interfere with swallowing imaging tests
  • People with a serious diagnosed gastrointestinal (digestive tract) disease
  • People who have had surgery on the stomach or oesophagus (food pipe)
  • People who have a history of head or neck cancer that has affected swallowing, or who have had surgical treatment in that area
  • People with a history of breathing conditions such as asthma or chronic obstructive pulmonary disease (COPD) that require assisted breathing support
  • People with untreated high blood pressure
  • People with heart disease that requires them to limit physical activity and receive ongoing medical management
  • People who have received speech therapy for swallowing difficulties within the past three months
  • Women who are pregnant, breastfeeding, or who plan to become pregnant during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giselle Carnaby, PhD, MP, The University of Texas Health Science Center at San Antonio

Phone: 210-450-7130

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The University of Texas Health Science Center at San Antonio
Registry
ClinicalTrials.gov
Start date
30 August 2026
Est. completion
30 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mann Assessment of Swallowing Ability (MASA); Modified Unified Parkinson Disease Rating Scale (MDS-UPDRS); Modified Hoehn and Yahr (HY) Scale; Montreal Cognitive Assessment (MoCA); PD Quality of Life Scale (PDQ-39)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov